Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Inicio
Ayuda y preguntas frecuentes
English
Español
Inicio
Unidades de investigación
Perfiles
Proyectos
Producción científica
Equipo
Premios
Actividades
Buscar por experiencia, nombre o afiliación
Epigenetics in Cardiovascular Disease
S. Aslibekyan
, S. A. Claas
, D. K. Arnett
Epidemiology & Environmental Health
College of Public Health
Producción científica
:
Chapter
›
revisión exhaustiva
3
Citas (Scopus)
Información general
Huella
Huella
Profundice en los temas de investigación de 'Epigenetics in Cardiovascular Disease'. En conjunto forman una huella única.
Clasificar por
Ponderación
Alfabéticamente
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Epigenetics
100%
Epigenomics
100%
Methylation
66%
Posttranslational Modification
66%
Histone
66%
Epigenetics
33%
Blood Lipids
33%
RNA
33%
Epigenome
33%
Histone Modification
33%
Epigenetic Therapy
33%
DNA Methylation
33%
Animal Experiment
33%
Infancy
33%
Cardiac Dysrhythmia
33%
Statin
33%
Dyslipidemia
33%
Programmed Cell Death
33%
Medicine and Dentistry
Cardiovascular Disease
100%
Epigenomics
100%
microRNA
33%
Protein Processing
22%
Histone
22%
Risk Stratification
22%
Ventricular Hypertrophy
22%
Congestive Heart Failure
22%
Atherosclerosis
22%
Methylation
22%
Combination Therapy
11%
Abdominal Aortic Aneurysm
11%
Health Care Cost
11%
Bromodomain Inhibitor
11%
Cardiovascular System
11%
Apoplexy
11%
Myocardial Infarction
11%
Programmed Cell Death
11%
Infancy
11%
Dyslipidemia
11%
Diabetic Cardiomyopathy
11%
Heart Muscle Injury
11%
Cardiac Dysrhythmia
11%
Acute Coronary Syndrome
11%
Statin
11%
Angina Pectoris
11%
Epigenetic Therapy
11%
DNA Methylation
11%
Histone Modification
11%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Disease
100%
microRNA
33%
Histone
33%
Atherosclerosis
22%
Heart Ventricle Hypertrophy
22%
Congestive Heart Failure
22%
Inflammation
22%
Abdominal Aortic Aneurysm
11%
Heart Infarction
11%
Heart Arrhythmia
11%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
11%
Acute Coronary Syndrome
11%
Cerebrovascular Accident
11%
Heart Muscle Injury
11%
Bromodomain Inhibitor
11%
Angina Pectoris
11%
Combination Therapy
11%
Diabetic Cardiomyopathy
11%
Dyslipidemia
11%